Neusoft Once Again Included in Gartner^® Market Guide for Enterprise Electronic Health Record Solutions

Recently, Neusoft has been included in the 2021 Gartner “Market Guide for Enterprise Electronic Health Record Solutions.” This is the second time Neusoft has been selected as the only Healthcare IT Vendors among the 26 global counterparts positioned.

Neusoft has more than 20 years’ innovative and practical experience in Healthcare IT Solutions. In 1997, Neusoft began to engage in Healthcare Informatization by focusing on core medical businesses. Basing on its continuous enhancement in such businesses, Neusoft developed niche clinical products and specialty capabilities. In 2019, Neusoft launched three industry-leading integrated solutions, RealOne Suite, CloudOne Suite and HealthOne Suite, for three types of customers, i.e. large medical institutions, small and medium-sized ones, and health commissions, entering a development stage of software empowerment for all medical scenarios.

Currently, Neusoft has served more than 400 Grade A hospitals and over 2,700 large medical institutions. And the company’s maturity assessment in electronic medical records and information interconnection has held a leading position in the industry.

Gartner, Market Guide for Enterprise Electronic Health Record Solutions, Sharon Hakkennes, Veronica Walk, 8 December 2021

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.